Editorial:post hocanalysis of SONIC trial
Author:
- 4 May 2015
- journal article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 41 (11) , 1210
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease – a SONIC post hoc analysisAlimentary Pharmacology & Therapeutics, 2015
- Patient-Reported Outcomes as Primary End Points in Clinical Trials of Inflammatory Bowel DiseaseClinical Gastroenterology and Hepatology, 2014
- Endoscopic Assessment and Treating to Target Increase the Likelihood of Mucosal Healing in Patients With Crohn’s DiseaseClinical Gastroenterology and Hepatology, 2014
- Adalimumab Induces Deep Remission in Patients With Crohn's DiseaseClinical Gastroenterology and Hepatology, 2014
- Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel diseaseInflammatory Bowel Diseases, 2012
- Infliximab, Azathioprine, or Combination Therapy for Crohn's DiseaseNew England Journal of Medicine, 2010
- Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's diseaseGastrointestinal Endoscopy, 2006